Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial



Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J, James, Martin W, Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D, Wall, Lucy, Watkinson, Anthony
et al (show 8 more authors) (2017) Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2 (8). 565 - 575.

[img] Text
TACE 2.pdf - Accepted Version

Download (784kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 13 Jun 2018 06:22
Last Modified: 11 Dec 2019 18:10
DOI: 10.1016/S2468-1253(17)30156-5
Open Access URL: https://www.sciencedirect.com/science/article/pii/...
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3022483
Repository Staff Access